PRFX
NASDAQ
$1.15
PRF Technologies Ltd (PRFX)
PainReform Ltd., a pharmaceutical company specializing in clinical stages, is dedicated to the development of therapies that provide an extended period of post-surgical pain relief in Israel. The company is headquartered in Tel Aviv, Israel.
Sector:
Healthcare
Target: $12 (+943.48%)
Market Cap
$7.36M
P/B Ratio
0.49
FCF 5Y CAGR
+60.45%
Free Cash Flow Yield
-67.33%
Price Chart
Valuation
Market Cap$7.36M
P/S239.77
P/B0.49
Profitability
Total Revenue (TTM)$17K
Gross Profit (TTM)-$53K
EBITDA-$4.13M
Operating Margin-16200%
Financial Health
Debt-to-Equity0.2%
Free Cash Flow Yield-67.33%
Growth & Risk
FCF 5Y CAGR+60.45%
Beta (5Y)1.48
Sharpe Ratio-0.25